Joseph J. Senn - Concepedia

Concepedia

Author

Joseph J. Senn

Moderna Therapeutics (United States)

Also Known As

J J Senn, J.J. Senn, Joseph J. Senn, Joseph Senn

22

Publications

4.8K

Citations

15

H-Index

36

Concepts

All Affiliations

Moderna Therapeutics (United States)Medical University of South Carolina University of Rochester Alnylam Pharmaceuticals (United States)Millennium Engineering and Integration (United States)

JJ

About

Joseph J. Senn is an author at Moderna Therapeutics (United States) specializing in cell biology, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Cell Biology	6	6	1.2K
3	Immunology	5	5	986
4	Health Sciences	2	2	862
5	Diabetes	2	2	862

Joseph J. Senn

×

15

Publications

4.8K

Citations

15

H-Index

	Year	Citations
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes Joseph J. Senn, Peter Klover, Irena Nowak, Diabetes	2002	868
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines Kimberly J. Hassett, Kerry E. Benenato, Eric Jacquinet, Molecular Therapy — Nucleic Acids	2019	841
A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates Staci Sabnis, E. Sathyajith Kumarasinghe, Timothy Salerno, Molecular Therapy	2018	753
Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes Joseph J. Senn, Peter Klover, Irena Nowak, Journal of Biological Chemistry ImmunologyInterleukin-6-dependent Insulin ResistanceInsulin ReceptorInsulin SignalingInflammation	2003	608
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials Robert Feldman, Rainard Fuhr, Igor Smolenov, Vaccine	2019	453
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor Robert A. Mooney, Joseph J. Senn, Scott J. Cameron, Journal of Biological Chemistry	2001	276
Toll-like Receptor-2 Is Essential for the Development of Palmitate-induced Insulin Resistance in Myotubes Joseph J. Senn Journal of Biological Chemistry Tlr2 ReceptorImmunologyCell DeathInsulin SignalingInflammation	2006	254
RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation Kumaran Sundaram, Riko Nishimura, Joseph J. Senn, Experimental Cell Research Systems BiologyBone Morphogenic ProteinBone RemodelingOsteoarthritisRank Ligand	2006	211
Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey Maja Sedic, Joseph J. Senn, Andy Lynn, Veterinary Pathology	2017	180
Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties Gilles Besin, Jaclyn Milton, Staci Sabnis, ImmunoHorizons	2019	99

Page 1